Is there high-quality evidence to support the use of Hilotherm in preventing chemotherapy-induced peripheral neuropathy?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18607901
Cited by: 0

Abstract

Evidence supports the use of cryotherapy in reducing chemotherapy-induced peripheral neuropathy, but specific high-quality evidence for Hilotherm devices is limited. Further research is needed to establish definitive conclusions.

Fields of Study & Subjects

Cancer Treatment and Pharmacology Chemotherapy-related skin toxicity Safe Handling of Antineoplastic Drugs

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 February 2026
Language
EN